U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501117) titled 'Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma' on March 17.
Brief Summary: The goal of this clinical trial is to investigate the safety and feasibility of neoadjuvant immunotherapy for patients with high-risk uveal melanoma. The main question is:
- Is neoadjuvant treatment with nivolumab and ipilimumab safe and feasible for patientt with high-riks uveal melanoma? In addition pathological response, distant metastases-free survival, overall survival and immunological changes in the tumor microenviroenment after therapy will be assesed.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Uveal Mela...